CClinicalTrials.gg
CompletedNCT01307280HEALTHUpdated Jan 26, 2012

Weight Management Demonstration Project: HEALTH

An interventional study of RCT1 and RCT2 in Weight Loss, sponsored by RTI International. Completed at 3 sites in United States. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2012-01-26.

Sponsored by RTI International · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
2,395
Allocation
Randomized
Ages
18 Years to 64 Years
Sex
All
01

Study summary

The study investigated the effectiveness and cost-effectiveness of a cognitive and behavioral weight management program, complemented by an interactive Web site and brief telephone coaching, implemented among TRICARE non-active-duty beneficiaries.

A total of 1,755 participants from four Midwestern states were randomized to one of three randomized controlled trial groups with increasing intervention intensity: mailed material and basic Web access (RCT1), plus an interactive Web site (RCT2), plus brief phone- and Web-based coaching support from health lifestyle coaches (RCT3). The study assessed changes in participants' weight, blood pressure, diet, and physical activity from baseline to 6, 12, and 15 to 18 months. Analyses estimated overall cost savings and calculated the cost-effectiveness ratio of each randomized controlled trial compared with a "do-nothing" alternative as the cost per quality-adjusted life year.

Read the detailed description

Lifestyle modification interventions that promote healthful eating habits and physical activity can be effective in producing weight losses of 4% to 9% of initial bodyweight. If maintained, this level of weight loss can reduce hypertension, high blood glucose, and elevated lipids. However, weight losses often plateau after 6 months, and weight regain begins after 12 months. Accordingly, there is interest in interventions, such as Web-based reinforcement and brief counseling to maintain weight loss over time and in the relative cost-effectiveness of program delivery modes.

Most obesity treatment programs focus on outcomes for individuals without assessing population-based cost savings. This study suggests that a broader perspective can help to identify the benefit of weight management in adult populations. Accordingly, this study assessed the cost-effectiveness of a weight management program in a population of adults served by a large health care system-the TRICARE Management Activity (TMA), the agency that manages the TRICARE health care benefits for active-duty service members, retired service members, their families, National Guard/Reserve members, and their families. The annual direct medical costs of overweight/obesity for beneficiaries enrolled in TRICARE Prime are estimated to exceed $1.1 billion. This study investigated the effectiveness and cost-effectiveness of methods to deliver a cognitive-behavioral weight loss intervention.

02

Conditions studied

  • Weight Loss

Keywords

  • Behavioral Weight Management Intervention
  • weight loss
  • cost-effective analysis
  • high blood pressure
  • randomized clinical trial
  • behavioral interventions
  • physical activity
  • dietary change
  • obesity
03

In context

Body Weight

1,223 studies on the registry are indexed under Body Weight; 131 are open to participants now.

This study's enrollment of 2,395 is above the median of 64 across 947 interventional studies indexed under Body Weight.

Browse Body Weight studies →

Lead sponsor

RTI International is the lead sponsor of 81 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • TRICARE Prime non-active-duty beneficiaries
  • Body Mass Index of 25 to 50
  • Living in 4 midwestern states (TRICARE region)

Exclusion criteria

Exclusion Criteria:

  • Not able to engage in physical activity
  • Pregnant
  • Body mass index greater than 50
  • Body mass index less than 25
  • Human immunodeficiency virus infected
  • current cancer
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2,395 participants (actual)

Study arms

  • Experimental
    Basic HEALTH

    Participants received the bookHEALTH manual and eHEALTH tools, the basic Internet component of the intervention

    Behavioral: RCT1

  • Experimental
    Interactive Internet

    Intervention intensity increased in RCT2, which included bookHEALTH and an interactive version of eHEALTH that provided tailored computerized feedback whenever participants submitted weekly assessments.

    Behavioral: RCT2

  • Experimental
    Behavioral Counseling

    RCT3 included bookHEALTH, the interactive version of eHEALTH, and telephonic coaching support provided by trained health lifestyle coaches every 2 weeks alternating between a telephone call (typically 15 to 20 minutes) and a personalized e-mail. The coaches used motivational interviewing, helped participants solve problems, and reinforced their successes.

    Behavioral: RCT3

Interventions

  • BehavioralRCT1

    the bookHEALTH manual and eHEALTH tools, the basic Internet component of the intervention

  • BehavioralRCT2

    bookHEALTH and an interactive version of eHEALTH that provided tailored computerized feedback whenever participants submitted weekly assessments

  • BehavioralRCT3

    bookHEALTH, the interactive version of eHEALTH, and telephonic coaching support provided by trained health lifestyle coaches every 2 weeks alternating between a telephone call (typically 15 to 20 minutes) and a personalized e-mail. The coaches used motivational interviewing, helped participants solve problems, and reinforced their successes.

06

What researchers measure

Primary outcomes

  1. Body Mass Index BMI

    Time frame: change in body mass index at baseline

  2. BMI

    Time frame: change in body mass index at 6 months

  3. BMI

    Time frame: change in body mass index at 12 months

  4. BMI

    Time frame: change in body mass index at 18 months

Secondary outcomes

  1. Blood Pressure

    Time frame: change in blood pressure at baseline, and 6,12,18 months

07

Study locations

3 sites
  • RTI Study Center
    Swansea, Illinois 62226, United States
  • RTI International
    Research Triangle Park, North Carolina 27709, United States
  • RTI Study Center
    Fairborn, Ohio 45324, United States
08

References and documents

Publications

  • Hersey JC, Khavjou O, Strange LB, Atkinson RL, Blair SN, Campbell S, Hobbs CL, Kelly B, Fitzgerald TM, Kish-Doto J, Koch MA, Munoz B, Peele E, Stockdale J, Augustine C, Mitchell G, Arday D, Kugler J, Dorn P, Ellzy J, Julian R, Grissom J, Britt M. The efficacy and cost-effectiveness of a community weight management intervention: a randomized controlled trial of the health weight management demonstration. Prev Med. 2012 Jan;54(1):42-9. doi: 10.1016/j.ypmed.2011.09.018. Epub 2011 Oct 6. PubMed 22001689 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 26, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01307280
Lead sponsor
RTI International
Collaborators
United States Department of Defense, The Cooper Institute, University of South Carolina
Responsible party
Sponsor
First posted
Mar 2, 2011
Start date
Aug 2006
Primary completion
Aug 2008
Completion
Dec 2009
Last update
Jan 26, 2012

Study contacts

James Hersey, PhD
principal investigator · RTI International

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion